Concepedia

Keiichi Enjyoji

KE

Statistics

Publications

70

Citations

5.5K

H-Index

38

Active since

1985

Affiliations

Beth Israel Deaconess Medical Center(Current)

Harvard University

National Cerebral and Cardiovascular Center

Kyushu University

Massachusetts Institute of Technology

Keiichi Enjyoji is an author at Beth Israel Deaconess Medical Center specializing in life sciences, biochemistry, and signal transduction.

Publications per year

1985–2022

70

Publications

70

Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation

Keiichi Enjyoji, Jean Sévigny, Yuan Lin et al. · Nature Medicine · 1999 · 575 citations

Medicine, Biochemistry, Molecular Biology +12

Coordinated Adenine Nucleotide Phosphohydrolysis and Nucleoside Signaling in Posthypoxic Endothelium

Holger K. Eltzschig, Juan C. Ibla, Glenn T. Furuta et al. · The Journal of Experimental Medicine · 2003 · 495 citations · Full text

Veterinary Medicine, Cell Biology, Physiology +17

CD39 is the dominant Langerhans cell–associated ecto-NTPDase: Modulatory roles in inflammation and immune responsiveness

Norikatsu Mizumoto, Tadashi Kumamoto, Simon C. Robson et al. · Nature Medicine · 2002 · 332 citations

Life Sciences, Immunology, Pathology +10

CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease

David J. Friedman, Beat Künzli, Yousif I. A-Rahim et al. · Proceedings of the National Academy of Sciences · 2009 · 283 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

CD39/ENTPD1 Expression by CD4+Foxp3+ Regulatory T Cells Promotes Hepatic Metastatic Tumor Growth in Mice

Xiaofeng Sun, Yan Wu, Wenda Gao et al. · Gastroenterology · 2010 · 274 citations · Full text

Medicine, Cancer Biology, Oncology +12

1–5 of 70